| Literature DB >> 17208674 |
Cheng K Ong1, Vincent F H Chong.
Abstract
The tongue enables taste and plays a critical role in formation of food bolus and deglutition. The tongue is also crucial for speech and the earliest sign of tongue paresis is a change in the quality of speech. Given the importance of the tongue, tongue carcinoma should be accurately staged in order to optimise treatment options and preserve organ function. The intent of this review is to familiarize radiologists with the pertinent anatomy of the tongue and the behaviour of tongue carcinoma so as to map malignant infiltration accurately. (c) International Cancer Imaging Society.Entities:
Mesh:
Year: 2006 PMID: 17208674 PMCID: PMC1766559 DOI: 10.1102/1470-7330.2006.0029
Source DB: PubMed Journal: Cancer Imaging ISSN: 1470-7330 Impact factor: 3.909
Figure 1(a) Axial T1 weighted image shows the tongue muscles, genioglossus (long arrow) and hyoglossus (short arrow). (b) Coronal T1 weighted image shows lingual septum (short arrow) and mylohyoid (long arrow), which forms the floor of the mouth.
Figure 2(a) Axial T2 weighted fat-suppression image shows a right-sided tongue cancer extending more than 5 mm from the lateral margin of the tongue. (b) Coronal T2 weighted fat-suppression image shows bilateral submandibular lymphadenopathy (arrows), a result of the lymphatic drainage pathways of the inner two-thirds of the oral tongue.
Figure 3(a) Axial T1 weighted, (b) post-contrast T1 weighted fat-suppression and (c) T2 weighted fat-suppression images show a left-sided oral tongue carcinoma. Note that the tumour is most conspicuous on T2 weighted fat-suppression sequence.
Figure 4(a) Axial post-contrast T1 weighted fat-suppression image shows a right-sided oral tongue carcinoma (arrow). (b) Coronal T2 weighted fat-suppression image shows tumour infiltration of the floor of the mouth (long arrow). Note the normal contralateral mylohyoid muscle (short arrow). (c) Coronal T2 weighted fat-suppression image of another patient shows a right-sided oral tongue cancer (short arrow). Note the sublingual glands (long arrows), which should not be confused as tumour infiltration.
Figure 5(a) Axial T2 weighted fat-suppression image shows a right-sided tongue base cancer (long arrows). An enlarged right jugulodigastric node is also seen (short arrow), the first echelon node of tongue base carcinoma. (b) Sagittal T2 weighted fat-suppression image of the same patient shows the extent of pharyngeal invasion of the tongue base tumour (arrow).
Figure 6Axial T1 weighted image shows a tongue cancer with mandible invasion. However, early involvement of cortical bones is better seen on CT images.
Figure 7(a) Sagittal T2 weighted fat-suppression image shows carcinoma in the anterior third of the oral tongue (arrow). (b) Sagittal T2 weighted fat-suppression image (same patient) shows tumour invading the floor of the mouth (arrow).
Figure 8(a) Coronal T2 weighted fat-suppression image shows a carcinoma in the middle third of the oral tongue with early infiltration (long arrow) of the tongue musculature (genioglossus). Note the ipsilateral submandibular lymphadenopathy (short arrow). (b) Coronal post-contrast T1 weighted fat-suppression image of a more advanced case shows the tumour invading the lateral floor of the mouth (arrow).
Figure 9(a) Axial post-contrast CT image shows a large left-side tongue base carcinoma. Note the extension across the midline (long arrow) and the ipsilateral enlarged jugulodigastric node (short arrow). (b) Axial post-contrast CT image shows tumour extension into the aryepiglottic (short arrow) and hypopharynx (long arrow).
Figure 10(a) Axial post-contrast T1 weighted fat-suppression image shows a large tongue base tumour (opposing arrows). (b) Axial post-contrast T1 weighted fat-suppression image shows inferior extension into the right pyriform fossa (arrow).
Figure 11(a) Axial post-contrast CT image shows an exophytic a left-sided vallecular cancer (arrows). (b) Axial post-contrast CT image shows tumour involving the ipsilateral aryepiglottic fold (short white arrow) and the pyriform sinus (long white arrow). Note the enlarged necrotic left jugulodigastric node (black arrow).
Figure 12Axial post-contrast CT image shows a tongue base carcinoma (black arrow) with bilateral malignant lymphadenopathy (white arrows), which occurs in up to 30% of patients on presentation.
Tumour Node Metastasis (TNM) classification
| T—Primary tumour | |
| TX | Primary tumour cannot be assessed |
| T0 | No evidence of primary tumour |
| Tis | Carcinoma |
| T1 | Tumour 2 cm or less in greatest dimension |
| T2 | Tumour more than 2 cm but not more than 4 cm in greatest dimension |
| T3 | Tumour more than 4 cm in greatest dimension |
| T4a (oral tongue) | Tumour invades through cortical bone, into deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), maxillary sinus, or skin of face |
| T4b (oral tongue) | Tumour invades masticator space, pterygoid plates, or skull base, or encases internal carotid artery |
| T4a (pharyngeal tongue) | Tumour invades any of the following: larynx, deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), medial pterygoid, hard palate, and mandible |
| T4b (pharyngeal tongue) | Tumour invades any of the following: lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, skull base; or encases the carotid artery |
| N—Regional lymph nodes | |
| NX | Regional lymph nodes cannot be assessed |
| N0 | No regional lymph node metastasis |
| N1 | Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension |
| N2 | Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension |
| N2a | Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension |
| N2b | Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension |
| N2c | Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension |
| N3 | Metastasis in a lymph node more than 6 cm in greatest dimension |
| M—Distant metastasis | |
| MX | Distant metastasis cannot be assessed |
| M0 | No distant metastasis |
| M1 | Distant metastasis |
Note: Midline nodes are considered ipsilateral nodes.
Stage grouping
| Stage 0 | Tis | N0 | M0 |
| Stage I | T1 | N0 | M0 |
| Stage II | T2 | N0 | M0 |
| Stage III | T1, T2 | NI | M0 |
| T3 | N0, N1 | M0 | |
| Stage IVA | T1, T2, T3 | N2 | M0 |
| T4a | N0, N1, N2 | M0 | |
| Stage IVB | Any T | N3 | M0 |
| T4b | Any N | M0 | |
| Stage IVC | Any T | Any N | M1 |